Pete Sessions stock trades
Pete Sessions disclosed 5 trades made in the last 12 months (5 sales). Most traded: AAPL (1), ABBV (1), ARCC (1). Across 21 trades with both dates on file, the median time from trade to disclosure was 3 days, against the STOCK Act deadline of 45 days; none was filed late.
Email me when Pete Sessions files a trade
A free account follows up to 10 members of Congress. New disclosures arrive in your daily or weekly digest. No password and no card.
Recent stock trades by Pete Sessions
| Trade date | Ticker | Side | Amount as filed | Days to disclose |
|---|---|---|---|---|
| 2026-09-22 | AAPL | Sell | $100,001 - $250,000 | 0 |
| 2026-09-14 | GOOGL | Sell | $15,001 - $50,000 | 4 |
| 2026-09-14 | ABBV | Sell | $15,001 - $50,000 | 4 |
| 2026-07-24 | ARCC | Sell | $1,001 - $15,000 | 0 |
| 2026-03-09 | VZ | Sell | $1,001 - $15,000 | 0 |
| 2025-06-12 | JNJ | Sell | $15,001 - $50,000 | 9 |
| 2025-06-12 | DHR | Sell | $50,001 - $100,000 | 9 |
| 2024-12-18 | MSFT | Buy | $1,001 - $15,000 | 1 |
| 2024-11-01 | NVDA | Buy | $1,001 - $15,000 | 0 |
| 2024-09-16 | NVDA | Buy | $1,001 - $15,000 | 0 |
| 2024-09-10 | NVDA | Buy | $1,001 - $15,000 | 2 |
| 2024-09-10 | MO | Sell | $1,001 - $15,000 | 2 |
| 2024-09-09 | MSFT | Buy | $1,001 - $15,000 | 3 |
| 2024-06-06 | NVST | Sell | $1,001 - $15,000 | 0 |
| 2024-05-21 | NVDA | Sell | $50,001 - $100,000 | 1 |
| 2024-03-20 | GIS | Sell | $1,001 - $15,000 | - |
| 2024-02-29 | V | Buy | $1,001 - $15,000 | 7 |
| 2024-02-07 | MSFT | Buy | $1,001 - $15,000 | 22 |
| 2024-01-31 | COST | Buy | $1,001 - $15,000 | 29 |
| 2023-12-28 | CCI | Sell | $1,001 - $15,000 | 27 |
| 2023-12-28 | BABA | Sell | $1,001 - $15,000 | 27 |
| 2023-12-28 | AMT | Sell | $1,001 - $15,000 | 27 |
Most traded stocks
Disclosure timeliness
The STOCK Act requires a trade to be reported within 45 days. Counted over 21 trades with both a trade date and a filing date on file; the longest gap was 29 days.
More Congress data
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms